Onconic Therapeutics Inc. Logo

Onconic Therapeutics Inc.

Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.

476060 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Onconic Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative drugs for cancer and gastrointestinal diseases. A subsidiary of Jeil Pharmaceutical, the company focuses on therapeutic areas with high unmet medical needs and significant market potential. Its development pipeline features novel treatments for acid-related conditions, including ZacuCorrection (zastaprazan), a next-generation potassium-competitive acid blocker (P-CAB) designed to treat gastroesophageal reflux disease. Onconic Therapeutics aims to advance its portfolio through clinical development and strategic collaborations to bring new therapeutic options to patients.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Onconic Therapeutics Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Share Issue/Capital Change
주권매매거래정지 (무상증자)
Korean 4.8 KB
2025-09-17 00:00
Share Issue/Capital Change
주요사항보고서(무상증자결정)
Korean 10.2 KB
2025-09-15 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP1366)(자스타프라잔시트르산염)의 약물상호작용 확인을 위한…
Korean 11.6 KB

Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.